UIM
ONC

USS Investment Management’s BeOne Medicines Ltd ONC Stock Holding History

USS Investment Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-106,001
Closed -$14.3M – 607
2022
Q3 		$14.3M Sell
106,001
-74,246
-41% -$12.8M 0.21% 103
2022
Q2 		$29.2M Buy
180,247
+74,350
+70% +$11.6M 0.29% 70
2022
Q1 		$20M Sell
105,897
-110,512
-51% -$23.5M 0.16% 131
2021
Q4 		$58.5M Buy
216,409
+34,565
+19% +$11.7M 0.44% 43
2021
Q3 		$66.1M Buy
181,844
+13,844
+8% +$4.53M 0.56% 35
2021
Q2 		$57.7M Hold
168,000
– – 0.46% 57
2021
Q1 		$58.4M Buy
168,000
+48,000
+40% +$15.9M 0.5% 59
2020
Q4 		$31M Hold
120,000
– – 0.28% 79
2020
Q3 		$34.3M Buy
+120,000
New +$28.2M 0.33% 74

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

USS Investment Management's ONC Position: Q4 2022 in Review

USS Investment Management sold out of BeOne Medicines Ltd (ONC) in Q4 2022, closing a stake of 106,001 shares — an estimated $14.3M sold.

USS Investment Management first reported a position in ONC in Q3 2020 and held it in 9 quarters. The position peaked at $66.1M in Q3 2021. 213 funds tracked by Wall St. Rank hold ONC as of Q4 2022.

  • USS Investment Management reported no remaining BeOne Medicines Ltd position as of Q4 2022 after selling out during the quarter.
  • USS Investment Management sold 106,001 BeOne Medicines Ltd shares in Q4 2022, an estimated $14.3M.
  • USS Investment Management first reported a position in BeOne Medicines Ltd in Q3 2020 and held it in 9 quarters.
  • USS Investment Management's BeOne Medicines Ltd position peaked at $66.1M in Q3 2021.
  • 213 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2022.

Based on USS Investment Management's 13F filing for Q4 2022, filed 13 Feb 2023.